HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prop 65

This article was originally published in The Tan Sheet

Executive Summary

Calif. bill requiring private litigants to include certificate of merit demonstrating good cause for public Prop 65 warnings signed by Gov. Gray Davis Oct. 8. Legislation cleared Assembly Sept. 13 and Senate a day later. SB 471, which aims to halt "abusive actions brought by private persons containing little or no supporting evidence," requires a private plaintiff to "consult with a person of appropriate knowledge and expertise to establish an exposure to a listed chemical" (1"The Tan Sheet" Aug. 6, p. 7). Separately, state's Office of Environmental Health Hazards Assessment is seeking public comments by Nov. 2 on first in series of Prop 65 draft regulatory amendments to "replace outdated terminology, to make grammatical corrections and to consolidate and alphabetize definition terms"

You may also be interested in...



Prop 65 Certificate Of Merit Exposure Specificity Urged By CHPA

Certificates of merit filed with private enforcement actions under California's Proposition 65 should include specific details about the alleged toxic exposures, the Consumer Healthcare Products Association says

Prop 65 Enforcement Measures Under Review In Calif. Assembly

Private actions alleging Prop 65 violations would have to be accompanied by a "certificate of merit" under a bill slated to be reviewed by the California Assembly's Appropriations Committee at a hearing on Aug. 22.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131463

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel